Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
343981“…HTN was diagnosed in her late twenties. She was previously trialed on eight different classes of antihypertensive medications excluding mineralocorticoid antagonists or potassium-sparing diuretics but HTN remained uncontrolled. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343982por Bakema, Robbert, Smirnova, Daria, Biri, Despina, Kocks, Janwillem W H, Postma, Maarten J, de Jong, Lisa A“…Eligible articles were randomized controlled trials and cohort studies assessing the effect of an eHealth intervention for pharmacotherapy management compared with usual care on pharmacotherapy management or clinical outcomes in patients with asthma or COPD, CVD, or diabetes. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343983por Shin, Dong-Yeop“…Decitabine, a hypomethylating agent, is known to be relatively effective in patients with AML. Numerous trials are ongoing to investigate the effects of novel drugs combined with hypomethylating agents, TP53-targeting agents or immunologic agents. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343984por Jenciūtė, Gabrielė, Kasputytė, Gabrielė, Bunevičienė, Inesa, Korobeinikova, Erika, Vaitiekus, Domas, Inčiūra, Arturas, Jaruševičius, Laimonas, Bunevičius, Romas, Krikštolaitis, Ričardas, Krilavičius, Tomas, Juozaitytė, Elona, Bunevičius, Adomas“…CONCLUSIONS: This study will provide in-depth insight into temporally and spatially precise trajectories of patients with cancer that will provide a novel digital health approach and will inform the design of future interventional clinical trials in oncology. Our findings will allow a better understanding of the potential clinical value of passively generated smartphone sensor data (digital phenotyping) for continuous and real-time monitoring of patients with cancer for treatment side effects, cancer complications, functional status, and patient-reported outcomes as well as prediction of disease progression or trajectories. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343985por Cross, Shane, Nicholas, Jennifer, Mangelsdorf, Shaminka, Valentine, Lee, Baker, Simon, McGorry, Patrick, Gleeson, John, Alvarez-Jimenez, Mario“…Data were gathered from 2 completed and 4 ongoing randomized controlled trials, 11 pilot studies, and over 1000 co-design sessions using MOST. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343986por Tsironikos, Georgios I., Potamianos, Petros, Zakynthinos, George E., Tsolaki, Vasiliki, Tatsioni, Athina, Bargiota, Alexandra“…Materials and Methods: Eligible randomized controlled trials (RCTs) were selected after a search in CENTRAL, Scopus, and PubMed. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343987por Mahoney, Kathryn, Gupta, Deepali, Li, Yong, Betancourt, Natalia, Das, Aanika, Campanaro, Ed, Schmidt, Pete“…VYD222 is a re-engineered version of adintrevimab, an Fc-modified mAb that has a robust safety data package and demonstrated clinically meaningful results in Phase 2/3 clinical trials for both treatment and prevention of COVID-19 (NCT04805671, NCT04859517). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343988por Wu, Qiong, Tong, Jiayi, Zhang, Bingyu, Zhang, Dazheng, Chen, Jiajie, Lei, Yuqing, Lu, Yiwen, Wang, Yudong, Li, Lu, Shen, Yishan, Xu, Jie, Bailey, L. Charles, Bian, Jiang, Christakis, Dimitri A., Fitzgerald, Megan L., Hirabayashi, Kathryn, Jhaveri, Ravi, Khaitan, Alka, Lyu, Tianchen, Rao, Suchitra, Razzaghi, Hanieh, Schwenk, Hayden T., Wang, Fei, Witvliet, Margot I., Tchetgen, Eric J. Tchetgen, Morris, Jeffrey S., Forrest, Christopher B., Chen, Yong“…BACKGROUND: The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomized trials before the Omicron variant’s emergence. The long-term durability of vaccine protection in this population during the Omicron period remains limited. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343989“…Data from randomized controlled trials (RCTs) and non‐RCTs were presented and synthesized separately. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343990por Hughes, Stephen F, Hendricks, Beverly D, Edwards, David R, Bastawrous, Salah S, Roberts, Gareth E, Middleton, Jim F“…These results may have important implications and this pilot study may lead to a series of trials that shed light on the mechanisms of ischaemia-reperfusion injury, including potential points of therapeutic intervention for pathophysiological conditions.…”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
343991por Herben, V. M., ten Bokkel Huinink, W. W., Dubbelman, A. C., Mandjes, I. A., Groot, Y., van Gortel-van Zomeren, D. M., Beijnen, J. H.“…The recommended dose for use in phase II clinical trials is topotecan 1.0 mg m-2 on days 1-5 and etoposide 40 mg bid on days 6-12 every 4 weeks.…”
Publicado 1997
Enlace del recurso
Enlace del recurso
Texto -
343992“…However, most studies do not reflect the more naturalistic and common ad libitum, or freely at will, use of the Internet. Randomized clinical trials, for example, typically include at least some direct contact with participants and often have restrictive selection criteria. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
343993por Zou, Peng, Povoski, Stephen P, Hall, Nathan C, Carlton, Michelle M, Hinkle, George H, Xu, Ronald X, Mojzisik, Cathy M, Johnson, Morgan A, Knopp, Michael V, Martin, Edward W, Sun, Duxin“…The antigen-directed and cancer-specific (124)I-radiolabled anti-TAG-72 monoclonal antibody conjugate, (124)I-HuCC49deltaC(H)2, holds future potential for use in human clinical trials for preoperative, intraoperative, and postoperative PET-based imaging strategies, including fused-modality PET-based imaging platforms.…”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
343994por Torreele, Els, Bourdin Trunz, Bernadette, Tweats, David, Kaiser, Marcel, Brun, Reto, Mazué, Guy, Bray, Michael A., Pécoul, Bernard“…To complete the preclinical development and meet the regulatory requirements before initiating human trials, the anti-parasitic properties and the pharmacokinetic, metabolic and toxicological profile of fexinidazole have been assessed. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
343995“…The preferred types of clinical studies for these evaluations are randomized controlled trials. However, all institutions do allow for other types of evidence (e. g. expert opinion) when no other study types of a higher evidence level are available. …”
Enlace del recurso
Enlace del recurso
Texto -
343996“…The medical analysis was initially based on systematic reviews of randomized controlled trials (RCT) and was followed by the evaluation of RCT with use of current optimal medical therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343997por Zimmerli, Lukas, Krewer, Carmen, Gassert, Roger, Müller, Friedemann, Riener, Robert, Lünenburger, Lars“…Medians for both arms show a gradual decrease and significant difference of the number of successful trials with increasing condition difficulty (F(2;60 )= 44.623; p < 0.01; η(2 )= 0.623) but no significant difference between paretic and non-paretic arm (F(1;60 )= 3.768; p = 0.057; η(2 )= 0.065). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343998“…BACKGROUND: In randomized controlled trials, participants cannot choose their preferred intervention delivery mode and thus might refuse to participate or not engage fully if assigned to a nonpreferred group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343999“…Randomised controlled trials (RCT), where applicable also containing relevant health economic evaluations and publications addressing the ethical, social and legal aspects of using bone graft substitutes for fracture treatment were included in the analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344000por Källander, Karin, Tibenderana, James K, Akpogheneta, Onome J, Strachan, Daniel L, Hill, Zelee, ten Asbroek, Augustinus H A, Conteh, Lesong, Kirkwood, Betty R, Meek, Sylvia R“…Lessons from mHealth trials and studies were summarized, focusing on low- and middle-income countries and community health workers. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto